S. Jackson

发表

Does age matter? The impact of rodent age on study outcomes

J. Latcham, A. Rice, S. Jackson, 2016, Laboratory animals.

Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials.

S. Jackson, Kathryn L Chapman, J. Valentin, 2016, Regulatory toxicology and pharmacology : RTP.

Minocycline Down-regulates MHC II Expression in Microglia and Macrophages through Inhibition of IRF-1 and Protein Kinase C (PKC)α/βII*

I. Duncan, S. Jackson, J. Watters, 2007, Journal of Biological Chemistry.

Fingolimod Enhances Myelin Basic Protein Expression and Modulates Cytokine Production Following an Interferon-gamma Mediated Insult in the Whole Brain Aggregate Cell Culture System

G. Giovannoni, S. Jackson, D. Baker, 2009 .

Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.

I. Duncan, S. Jackson, J. Watters, 2007, The Journal of biological chemistry.

Fingolimod modulates microglial activation to augment markers of remyelination

G. Giovannoni, S. Jackson, D. Baker, 2011, Journal of Neuroinflammation.

Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process.

S. Authier, S. Jackson, J. Valentin, 2019, Journal of pharmacological and toxicological methods.

Big conductance calcium‐activated potassium channel openers control spasticity without sedation

A. Irving, G. Giovannoni, S. Jackson, 2017, British journal of pharmacology.

Neuroprotection in a Novel Mouse Model of Multiple Sclerosis

Gavin Giovannoni, Samuel J. Jackson, David Baker, 2013, PloS one.

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.

G. Giovannoni, S. Jackson, G. Pryce, 2012, Multiple sclerosis and related disorders.

Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis

G. Giovannoni, S. Jackson, G. Pryce, 2011, Multiple sclerosis.

Multiple sclerosis: a practical overview for clinicians.

G. Giovannoni, S. Jackson, K. Rejdak, 2010, British medical bulletin.

Quantification of Myelin and Axon Pathology During Relapsing Progressive Experimental Autoimmune Encephalomyelitis in the Biozzi ABH Mouse

I. Duncan, S. Jackson, JangEun Lee, 2009, Journal of neuropathology and experimental neurology.

Cannabinoid‐mediated neuroprotection following interferon‐gamma treatment in a three‐dimensional mouse brain aggregate cell culture

M. Cuzner, D. Baker, S. Jackson, 2004, The European journal of neuroscience.

Role for TGF‐β1, FGF‐2 and PDGF‐AA in a myelination of CNS aggregate cultures enriched with macrophages

M. Cuzner, S. Jackson, L. Diemel, 2003, Journal of neuroscience research.

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.

A. Thompson, M. Cuzner, C. Ledent, 2003, Brain : a journal of neurology.

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis

G. Michael, G. Giovannoni, S. Jackson, 2013, PloS one.

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis

C. Ledent, G. Giovannoni, T. Yamamura, 2008, Journal of Neuroimmunology.

Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates

P. Szekeres, M. Hutton, M. Goedert, 2014, The Journal of Biological Chemistry.

Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau

P. Szekeres, M. Hutton, M. Goedert, 2016, The Journal of Neuroscience.

Human tissue models in cancer research: looking beyond the mouse

Gareth J. Thomas, Samuel J. Jackson, G. Thomas, 2017, Disease Models & Mechanisms.

A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

Zeshan Ahmed, Tracey K. Murray, Markus Tolnay, 2014, Acta Neuropathologica.

Cannabinoids and neuroprotection in CNS inflammatory disease

D. Baker, S. Jackson, G. Pryce, 2005, Journal of the Neurological Sciences.

Cannabinoids for the Control of multiple Sclerosis

S. Jackson, G. Pryce, D. Baker, 2008 .

Cannabinoid control of neuroinflammation related to multiple sclerosis

S. Jackson, G. Pryce, D. Baker, 2007, British journal of pharmacology.

Remyelination of cytokine‐ or antibody‐demyelinated CNS aggregate cultures is inhibited by macrophage supplementation

M. Cuzner, S. Jackson, L. Diemel, 2004, Glia.

Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation

M. Cuzner, S. Jackson, D. Baker, 2005, Neuroscience.

Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse

S. Jackson, B. Morgan, J. Neal, 2015, Clinical and experimental immunology.

Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau

P. Szekeres, M. Hutton, M. Goedert, 2016, The Journal of Neuroscience.